Patent Yard Sign in
Expired Canadian patentCanada

Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents

CA 2496203 C · Owner: Chao, Wan-Ru · Inventors: Jong, Ling; Chao, Wan-Ru

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Novel compounds useful , as chemotherapeutic and chemopreventive agents are provided. The compounds are analogs of indole-3-carbinol metabolites wherein the structures and substituents of the compounds are selected to enhance the compounds' overall efficacy, particularly with respect to therapeutic activity, oral bioavailability, long-term safety, patient tolerability, and therapeutic window. The compounds are useful not only in , treatment of cancer but also in prevention of cancer. One preferred class of the novel compounds have the structure of formula (I) wherein R1, R2, R3, R4, R5, R6, R7, R8 R9, R10 R11, and R12 are defined herein. Pharmaceutical compositions are provided …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed August 15, 2003 and granted March 27, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended August 15, 2023.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 15, 2025.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledAugust 15, 2003
GrantedMarch 27, 2012
Term endedAugust 15, 2023
Patent numberCA 2496203 C
Classification (IPC)C07D487/04 +2 more

Timeline

Timeline From CIPO dates

2004200620082010201220142016201820202022Application filedAug 15, 2003Patent grantedMarch 27, 2012Term endedAug 15, 2023

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.